Developing Allosteric Chaperones for GBA1-Associated Disorders-An Integrated Computational and Experimental Approach
Martedì 24 dicembre 2024
ca. 1 min. di lettura
Journal and Affiliations:
International Journal of Molecular Sciences, 24 dicembre 2024
Manolo Bellotto, GT Gain Therapeutics, Lugano
Tags:
Gaucher disease
GBA1
glucocerebrosidase
lysosomal storage disease
lysosome
Parkinson’s disease
pharmacological chaperone
Authors:
Manolo Bellotto